Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Sprint Interval Training in Young Sedentary Adults (SIT)

19. mai 2026 oppdatert av: Sezer Taştan

Effects of Sprint Interval Training on Cardiovascular Capacity and VO2max in Young Sedentary Adults: A Randomized Controlled Trial

This randomized controlled trial evaluated the effects of a 6-week supervised sprint interval training program on cardiorespiratory fitness in healthy sedentary young adults. Forty participants aged 20 to 25 years were randomly assigned to either a sprint interval training group or a control group. The sprint interval training group completed supervised cycle-ergometer sessions three times per week for 6 weeks, while the control group maintained their usual sedentary routine. The primary outcome was maximal oxygen uptake (VO2max). Secondary outcomes included resting heart rate and 6-minute walk test distance. The study aimed to determine whether a short-term, time-efficient sprint interval training program could improve cardiovascular capacity and functional exercise performance in sedentary young adults.

Studieoversikt

Detaljert beskrivelse

This study was designed as a randomized controlled pre-test and post-test intervention study. Healthy sedentary adults aged 20 to 25 years were enrolled after ethics approval and written informed consent. Participants were randomly allocated in a 1:1 ratio to either a supervised sprint interval training group or a control group.

The sprint interval training group performed supervised exercise sessions on a cycle ergometer three times per week for 6 weeks. Each session included a 5-minute warm-up, followed by repeated 30-second all-out sprint bouts with active recovery periods. The number of sprint repetitions was progressively increased during the intervention period. The control group maintained their usual sedentary lifestyle and did not receive an additional exercise program.

Outcome measurements were performed before and after the intervention. The primary outcome was VO2max, assessed using a maximal exercise test on a cycle ergometer with respiratory gas analysis. Secondary outcomes were resting heart rate and 6-minute walk test distance. Adherence and adverse events were monitored throughout the study period.

Studietype

Intervensjonell

Registrering (Faktiske)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • Aged 20-25 years
  • Healthy sedentary adult
  • Engaging in less than 150 minutes/week of moderate-to-vigorous physical activity
  • IPAQ score below 600 MET-min/week or not participating in a regular exercise program
  • Willing to provide written informed consent

Exclusion Criteria:

  • History of cardiovascular, pulmonary, or metabolic disease, such as hypertension or diabetes
  • Musculoskeletal injury or orthopedic condition preventing exercise participation
  • Pregnancy or breastfeeding
  • Smoking
  • Regular medication use

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Sprint Interval Training Group
Participants in this group completed supervised sprint interval training sessions on a cycle ergometer three times per week for 6 weeks.
The sprint interval training intervention consisted of supervised cycle-ergometer sessions performed three times per week for 6 weeks. Each session included a 5-minute warm-up at 50% VO2max, followed by 4 to 6 repetitions of 30-second all-out sprint bouts on a Monark 894E cycle ergometer, with 4-minute active recovery periods between sprints. The number of sprint repetitions was progressively increased from 4 repetitions in the first two weeks to 6 repetitions in the following four weeks.
Andre navn:
  • SIT
Ingen inngripen: Control Group
Participants in this group maintained their usual sedentary routine and did not receive an additional exercise program during the study period.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Maximal Oxygen Uptake (VO2max)
Tidsramme: Baseline and 6 weeks
VO2max was assessed using a maximal exercise test on a cycle ergometer with breath-by-breath respiratory gas analysis. VO2max values were recorded in ml/kg/min before and after the 6-week intervention.
Baseline and 6 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Resting Heart Rate
Tidsramme: Baseline and 6 weeks
Resting heart rate was measured in the morning after 10 minutes of seated rest using a heart rate monitor. Values were recorded in beats per minute before and after the 6-week intervention.
Baseline and 6 weeks
Change in 6-Minute Walk Test Distance
Tidsramme: Baseline and 6 weeks
Functional exercise capacity was assessed using the 6-minute walk test. The total distance covered in 6 minutes was recorded in meters before and after the 6-week intervention.
Baseline and 6 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Sezer Taştan, phD, Ankara Demirspor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

11. mars 2026

Primær fullføring (Faktiske)

22. april 2026

Studiet fullført (Faktiske)

22. april 2026

Datoer for studieregistrering

Først innsendt

13. mai 2026

Først innsendt som oppfylte QC-kriteriene

13. mai 2026

Først lagt ut (Faktiske)

19. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

22. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere